Average Co-Inventor Count = 4.36
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (10 from 3,681 patents)
2. Other (1 from 832,680 patents)
11 patents:
1. 10052360 - Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule
2. 9296808 - Methods for treating scleroderma by administering a soluble CTLA4 molecule
3. 9012408 - Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
4. 8722632 - Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule
5. 8703718 - Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule
6. 8497247 - Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule
7. 8435952 - Method for retarding progression to definite rheumatoid arthritis in subjects with undifferentiated arthritis
8. 8227420 - Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
9. 8148332 - Method for treating a rheumatic disease using a soluble TLA4 molecule
10. 7915222 - Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
11. 7455835 - Methods for treating immune system diseases using a soluble CTLA4 molecule